Syngen Biotech Co.,Ltd.

Research Syngen Biotech Co.,Ltd. (8279.TWO) on Bullrun: market cap TWD 2.19B, P/E 9.7, dividend yield 6.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 2.19B; P/E is 9.7; dividend yield is 6.2%.

Peer valuation comparison

Latest P/E is 9.72x versus a Healthcare sector median of 21.8x (55.4% below).

Latest dividend yield is 6.18% versus a Healthcare sector median of 2.4% (157.5% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 2.19B9.76.2%5

Dividend history

Latest trailing dividend snapshot: annual dividend/share 5 TWD, yield 6.2%.

About Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, and capsules;

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO)

Frequently asked questions

What is Syngen Biotech Co.,Ltd.'s market cap?

Syngen Biotech Co.,Ltd.'s market capitalization is TWD 2.19B.

What is Syngen Biotech Co.,Ltd.'s P/E ratio?

Syngen Biotech Co.,Ltd.'s price-to-earnings (P/E) ratio is 9.7.

Does Syngen Biotech Co.,Ltd. pay a dividend?

Syngen Biotech Co.,Ltd. has a dividend yield of 6.2%.

What does Syngen Biotech Co.,Ltd. do?

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally.